Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Restrictive Transfusion Strategy Early After Cardiac Surgery

NCT02761564 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT02761564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02761564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Restrictive Transfusion Strategy Early After Cardiac Surgery
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
October 6, 2016
Completion date
October 17, 2018
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia (<9g/dl) requiring blood transfusion, bleeding graded as insignificant, mild, moderate of universal definition of perioperative bleeding, central venous catheter on the superior vena cava (to perform scvo2 measure), hemodynamic and respiratory stability, undergoing nonemergent cardiac surgery